The ABC's of medical statistics. Reading and understanding clinical trials;Das ABC der medizinischen Statistik. Klinische Studien lesen und verstehen

Anaesthesist

Volumn 60, Issue 1, 2011, Pages 79-90

  Labenz, J ^a   Kunz, C U ^b  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Evidence based medicine; Meta analysis; Non inferiority study; Randomized controlled trial; Surrogate marker

Indexed keywords

ARTICLE; CALCULATION; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); GOLD STANDARD; HUMAN; META ANALYSIS (TOPIC); PARAMETER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; STATISTICAL ANALYSIS; STATISTICS;

CLINICAL TRIALS AS TOPIC; CONFIDENCE INTERVALS; CONTROLLED CLINICAL TRIALS AS TOPIC; ENDPOINT DETERMINATION; EVIDENCE-BASED MEDICINE; HUMANS; META-ANALYSIS AS TOPIC; PROBABILITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RETROSPECTIVE STUDIES; REVIEW LITERATURE AS TOPIC; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR; STATISTICS AS TOPIC;

EID: 79251640117     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-010-1840-5     Document Type: Article

References (17)

1. Connor JT (2009) Statistical graphics in AJG: save the ink for the information. Am J Gastroenterol 104: 1624-1630
2. Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315: 1533-1537
3. Evidence-Based Medicine Working Group, Guyatt G, Cairns J, Churchill D et al. (1992) Evidence-based medicine. A new approach to teaching practice of medicine. JAMA 268: 2420-2405
4. Falck-Ytter Y, Kunz R, Guyatt GH, Schünemann HJ (2008) How strong is the evidence? Am J Gastroenterol 103: 1334-1338
5. Greenhalgh T (1997) Statistics for the non-statistician. II .,Significant" relations and their pitfalls. BMJ 315: 422-425
6. Hammer GP, Prel JB du, Blettner M (2009) Vermeidung verzerrter Ergebnisse in Beobachtungsstudien. Dtsch Arztebl Int 106: 664-668
7. Kastelein JJ, Akdim F, Stroes ES et al. (2008) Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 358: 1431-1443
8. Labenz J, Blum AL, Bayerdörffer E et al. (1997) Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112: 1442-1447
9. Lagakos SW (2006) The challenge of subgroup analyses - reporting without distorting. N Engl J Med 354: 1667-1669
10. Moore MJ, Goldstein D, Hamm J et al. (2007) Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the national cancer institute of canada clinical trials group. J Clin Oncol: 1960-1966
11. Nuesch E, Trelle S, Reichenbach S et al. (2009) The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study. BMJ 339: 679-683
12. Sackett DL, Rosenberg WMC, Gray JA et al. (1996) Evidence-based medicine: what it is and what it isn't. BMJ 312: 71-72
13. Schoenfeld PS (2005) Evidence-based medicine in practice: applying intentionto-treat analysis and perprotocol analysis. Am J Gastroenterol 100: 3-4
14. Shakespeare TP, Gebski VJ, Veness MJ, Simes J (2001) Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours. Lancet 357: 1349-1353
15. Tinmouth JM, Steele LS, Tomlinson G, Glazier RH (2004) Are claims of equivalency in digestive diseases trials supported by the evidence? Gastroenterology 126: 1700-1710
16. Weihe W (2004) Von der Wahrscheinlichkeit des Irrtums. Dtsch Arztebl 101: 82-836
17. Yuan Y, Hunt RH (2009) Systematic reviews: the good, the bad, and the ugly. Am J Gastroenterol 104: 1086-1092